The company's standalone revenue from operation fell 25.20 per cent to Rs 5,783 crore for the March quarter as compared to Rs 7,732 crore in the year-ago period
The board of directors has recommended a final dividend of 606% at Rs 60.60 per share for the financial year 2022-23
The ITC stock closed at Rs 419.65 on the BSE, down 1.87 per cent
The company's consolidated net revenue from operation rose by 12.45 per cent to Rs 12.37 crore for the March quarter as compared to Rs 11 crore in the year-ago period
The country's largest listed oral care company posted a gross margin expansion of 100 basis points (bps) on a sequential basis to 66.9 per cent, led by pricing and efficient sourcing
The Ahmedabad-based company's net profit rose 17% to 970 million rupees, aided by a sharp drop in expenses
The company's consolidated interest income rose by 22.32 per cent to Rs 1,589 crore for the March quarter as compared to Rs 1,299 crore in the year-ago period
LT Foods also exports rice to more than 60 countries like the United States and in geographies such as Europe, the Middle East and the Far East
In the whole year, 2022-23, IndiGo reported a net loss of Rs 305.80 crore
CLOSING BELL ON MAY 18: The NSE Nifty 50 slipped 52 points to 18,130 as weekly expiry also weighed on the sentiment.
The company's sale of products rose by 50.7 per cent to Rs 2,559 crore for the March quarter as compared to Rs 1,698 crore in the year-ago period
State-owned firm's natural gas marketing business, its mainstay, reports decline in profit
ITC Q4 results: The revenue from operations rose 6.5 per cent to Rs 17,506.8 crore during the quarter
The company said that the order book for the year stood at a consolidated level stood of Rs 8,788 crore, as compared to Rs 9,410 crore in FY22, down 7 per cent
During the whole year, FY23, the company's net profit has nearly halved to Rs 5,301.5 crore
Zydus Lifesciences Ltd on Thursday reported a 25.36 per cent decline in consolidated net profit at Rs 296.6 crore in the fourth quarter ended March 31, 2023 impacted by impairment of goodwill of a wholly-owned subsidiary. The company, which had posted a consolidated net profit of Rs 397.4 crore in the same quarter of the previous fiscal, said its board has recommended a final dividend of Rs 6 per equity share of Re 1 each, subject to approval of shareholders at the Annual General Meeting scheduled to be held on August 11, 2023. Consolidated total revenue from operations stood at Rs 5,010.6 crore, as against Rs 3,805.6 crore in the corresponding period a year ago, Zydus Lifesciences said in a regulatory filing. Total expenses were higher at Rs 3,961.3 crore, as compared to Rs 3,311.8 crore in the year-ago quarter. During the quarter, Zydus Lifesciences said it incurred an exceptional item of Rs 594.1 crore as impairment of goodwill by Sentynl Therapeutics Inc, a wholly-owned subsidi
Technically, State Bank of India's shares are well placed above the breakout mark of Rs 565 from a short-term to medium-term perspective.
State Bank of India Q4 earnings: The Board has declared a dividend of Rs 11.30 per share @ 1,130 per cent for the year ending March 31, 2023
At 12:11 pm; the stock was up 2.8 per cent at Rs 752.15, with a market capitalisation of Rs 50,154 crore, the BSE data shows.
The gain in NASDAQ thus far in CY23 was largely fueled by Google, Apple, Amazon, Netflix and Meta Platforms - also known as the FAANG stocks.